“Molecular surveillance, including next generation sequencing, continues to monitor changes to the virus to ensure that current tests remain accurate.” “There is no current evidence that a new variant is spreading that is not detectable by FDA authorized tests,” Fischer said. The good news is: that doesn’t appear to be the case. We’ve all heard about new variants spreading, so it’s fair to wonder if there might be a new variant tricking Covid-19 tests more than ever before. The earlier the virus is detected the more effective it will be in reducing both disease and spread.” “Merck’s new antiviral Molnupiravir blocks the virus from replicating. Those affected were contacted as soon as possible.“As oral antivirals for Covid get closer to approval, it is crucial to minimize false negative results for both symptomatic and asymptomatic individuals,” Fischer explained. “We suspended testing at the Immensa Wolverhampton laboratory following an ongoing investigation into positive LFD results subsequently testing negative on PCR.
#Picture of negative covid test results update
With a tidal wave of Omicron sweeping the country people need to know that test and trace won’t fail to protect them and their families and friends again.”ĭr Will Welfare, the incident director for Covid at the UKHSA, said: “A full investigation remains ongoing and we will provide an update in due course we cannot comment on any information that could form part of these investigations before they are complete. “Ministers have failed to provide an account of what happened and to implement proper safety checks at private labs to prevent this ever happening again.
Jo Maugham, the director of Good Law Project, said: “A box-fresh unaccredited testing company was given a huge public contract it then delivered tens of thousands of false negative test results. Part of the Good Law Project’s judicial review effort is to seek better safety checks at private labs, arguing that the false negative results contributed to the spread of Covid in the south-west and put people in danger. However, it was only on 12 October when “it was determined that the likely cause was a technical issue at the Immensa laboratory, and the laboratory ceased processing samples”. On 14 September, it said, UKHSA “was alerted to an unusual spike in the number of people testing positive on lateral flow devices but negative on PCR tests”, and looked at possible causes including potentially faulty lateral flows and “any link to school-age children”, an apparent reference to the efforts by some students to create artificially false test results. Responding to the pre-action letter, the government legal department set out the background to the accreditation of testers, and the chronology for the Immensa site.
The organisation argues the lack of a proper system to monitor the accuracy of tests at such labs breached the Department of Health and Social Care’s duty to protect life, and the human rights of those affected.
But separately, the Good Law Project has filed judicial review proceedings to, it said, “ensure the government addresses the multiple failures in their oversight of the Immensa lab”. The UKHSA, the successor body to Public Health England, is considering legal action against Immensa. Test and trace said about 400,000 samples had been processed through the lab, the vast majority of which were negative results, but an estimated 43,000 people may have been given incorrect negative PCR test results, mostly in south-west England. NHS test and trace suspended testing operations at the Wolverhampton centre after investigating the anomalous results. According to a government response to a pre-legal action letter from the Good Law Project, the decision to stop the lab processing tests then only happened on 12 October.
0 kommentar(er)
